Ajax-Loading

Boston Scientific Corp - Price To Sales Ratio

Boston Scientific Corp's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 7.35 as of 09/30/2025, the lowest value since 06/30/2024.

As of the end of Boston Scientific Corp's third quarter, the item "Price To Sales Ratio" stands at 7.35. This represents a decrease of -12.75 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.34 percent compared to the value the year prior.
The 1 year change in percent is -4.34.
The 3 year change in percent is 56.76.

The Serie's long term average value is 6.48. It's latest available value, on 09/30/2025, is 13.51 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +60.30%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -12.75%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoAbbott Laboratories - Price To Sales Ratio217,696,616,448.00
LogoIntuitive Surgical Inc - Price To Sales Ratio206,245,888,000.00
LogoEssilorLuxottica S. A. - Price To Sales Ratio172,241,486,586.05
LogoDanaher Corporation - Price To Sales Ratio162,006,663,168.00
LogoStryker Corporation - Price To Sales Ratio139,209,850,880.00